# XORTX Therapeutics Inc.: Form 6-K, filed Oct 18, 2024

- Company: [XORTX Therapeutics Inc.](/companies/xrtx.md) (CIK 1729214)
- Form: 6-K
- Filed: 2024-10-18
- Accepted by EDGAR: Oct 18, 2024, 17:22 ET
- Period: 2024-10-18
- Accession: 0001104659-24-109911
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1729214/000110465924109911/tm2425989d4_6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729214/000110465924109911/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729214/000110465924109911/tm2425989d4_6k.htm

Filed Oct 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-109911. Last ingested by Listed: Nov 14, 2026, 22:48 ET. No prices; not investment advice.
